the plot is that the president and ceo altered images in university research a decade ago presumably for an alzheimers drug that is the subject of the present business model. $200 million ipo in september 2020. the accumulated losses in the income statement translated into a $1 billion market cap before the june 2021 announcement. 35 million shares outstanding, institutions hold 27 million.
much opportunity for sophisticated actors to conduct even cursory diligence
the board placed the ceo on leave with a sniff of integrity.
thinking there has to be more to the story
Comments